Regulatory science for medical devices, SaMD, IVD, NAMs, ATMPs, pharmaceuticals
CoLAB Trials
Service ID:
EP367S3CoLAB TRIALS has in-house expertise on regulatory science for health products - medical devices (MD) (including Software as MD - SaMD), In vitro Diagnostic (IVD) devices, New Approach Methodologies (NAMs including Biomarkers), Medicinal products (including Pharmaceuticals and Advanced Therapy Medicinal Products). This service is directed to EIC Transition, EIC Accelerator, innovators. This service is designed to meet your specific needs. For MD, SaMD and IVD, our support may include device classification, regulatory strategy, clinical development strategy, technical and clinical documentation preparation for device certification (under MDR or IVDR), notified body selection and mediated interactions, partner search (for necessary regulatory, pre-clinical or clinical activities). For Medicinal products, our support may include product classification, regulatory strategy, pre-clinical study design, clinical development strategy, mediated interaction with regulators, including EMA advice mechanisms. In addition, for biomarkers and NAMs, we support documentation & report preparation and mediate EMA regulatory acceptability process (NAM qualification). We support the design of pre-clinical studies (identification of tests and models, selection of controls, study design). We support clinical validation of health products in compliance with ethical guidelines and EU regulations, including the activities of study design, protocol writing, risk management, clinical evaluation plan and report, regulatory submissions to authorities and ethics committees (outsourced), eCRF preparation and parametrization with audit trail. EIC beneficiaries and innovators will benefit from a more efficient journey to clinical trials and market approval/certification, with collection of appropriate and robust scientific and clinical evidence, aligned with ethical, scientific and regulatory requirements (MDR, IVDR, CTR, GDPR, 3Rs, GCP).
Standard price is €200/hour. For EIC beneficiaries, the discount price is €150/hour (correspondent to 25% discount rate). However, the service could be delivered as a budgeted project instead of an hourly rate. The total budget per service is dependent on the number of activities requested and their complexity.
Each requested service will be specific and focused on the type of health product (medical devices, SaMD, in vitro diagnostic devices, pharmaceuticals, advanced therapy medicinal products, new approach methodology), according to the project. Each service will be delivered as a project in which several and all activities can be requested and delivered, and a close collaboration with internal teams and CoLAB TRIALS will be maintained along service provision through multiple meetings to exchange and discuss information. The service will be delivered considering the EU regulatory landscape. The duration of the service varies according to its complexity.
Access to Infrastructure & R&D Support
Are you in doubt if this is the right service for you, or do you want to get more information about the service? Get in touch with the EIC Partner providing this service through this query form!
Is this the service you are looking for? If so, you can apply to the service through EIC ACCESS+! Eligible applicants can also get co-funding through the EIC ACCESS+ initiative. Find out more on the project webiste.
Receive up to €60,000 in grants, covering up to 50% of the costs, to access specialised services from the EIC Service Catalogue. Learn more on the EIC ACCESS+ website.